key: cord-0871595-01evo8h1 authors: Moran, Alexandra; Kim, Esther S.H.; Beckman, Joshua A.; Aday, Aaron W. title: Vascular Medicine in the COVID-19 Era: the Vanderbilt Experience date: 2020-07-30 journal: J Vasc Nurs DOI: 10.1016/j.jvn.2020.07.008 sha: 204312b4e86df8507f61f6a3b377c8c38ce99c8c doc_id: 871595 cord_uid: 01evo8h1 • COVID-19 poses significant risks for patients with vascular disease; • Telemedicine can help clinicians care for patients with vascular disease while socially distancing due to COVID-19; • Diagnosis-based algorithms helped clinicians identify candidate patients for telemedicine versus in-person evaluation; • These algorithms guided clinicians in both the inpatient and outpatient setting. In December 2019, a series of pneumonia cases of unknown cause emerged in Wuhan, Hubei, China [1] . Analyses of lower respiratory tract samples identified the culprit as a novel coronavirus subsequently named severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) [1] . SARS-CoV2 and its associated respiratory illness, coronavirus disease of 2019 (COVID-19), then spread internationally leading to the declaration of a pandemic by the World Health Organization on March 11, 2020 [2] . It quickly became clear that vascular disease is a major source of morbidity and mortality for patients with COVID-19. Post-mortem analysis of lung tissue from patients with COVID-19 revealed extensive small vessel endothelial injury, thrombosis, and microangiopathy [3] . Early data also suggest COVID-19 increases risk for both venous and arterial thromboembolism [4, 5] . In Italy, one of the countries hardest hit by the pandemic, reduced physical activity and fear of seeking medical care may have contributed to later presentations and worse outcomes for patients with peripheral artery disease (PAD) [6] . Therefore, it is critical that vascular clinicians remain engaged in both inpatient and outpatient care during the pandemic. Although social distancing is necessary to mitigate spread of the virus among both patients and providers, this presents significant challenges to the provision of high quality care. As vascular medicine providers, we rely on the nuances of the physical examination to evaluate, diagnose, and manage our patient population. Palpating peripheral pulses, auscultating bruits, and inspecting lower extremities for pigmentation changes and ulcers are essential components of our clinical practice. Much of our clinical decision-making depends upon diagnostic imaging, and a single patient may require multiple imaging studies over a short time frame. Finally, many of our medical therapies, particularly anticoagulant and antithrombotic agents, require close follow-up and/or laboratory monitoring. As a result, a means to provide many forms of vascular care from a physical distance became paramount. Telemedicine (TM), which is the use of telecommunications technology to provide health care from a distance, has found increasing use in recent years, especially for patients with chronic diseases. Components of TM include educational websites, telecoaching, telemonitoring, telerehabilitation, and/or teleconsultation (Table 1) [7] . Telemedicine was adopted early for patients with heart failure (HF). Numerous TM management strategies have been developed to reduce rehospitalizations, morbidity, mortality, and costs [7] . Despite the variety of tested strategies in this patient population, supportive data remain mixed, and applications of these efforts remain encumbered by regulatory, payer, and other policy issues [7] . Nonetheless, great interest in TM services remain, spurred by the shift from a fee-for-service to a value-based healthcare model. Limited data support the use of TM for patients with vascular disease. In an exploratory study of patients with critical limb ischemia (CLI), eleven individuals underwent interviews regarding their perceptions of telemedicine. Eight in ten participants had home internet service, and 50% felt comfortable using technology on their own [8] . Following lower extremity revascularization for PAD, telemonitoring and telecoaching have been used ranging from a wound imaging application to remote vital sign monitoring, and telehealth-based questionnaires regarding intermittent claudication [9] . One such example is implementation of the WoundCheck application as part of a 14-day postoperative follow-up protocol [10] . This application allows patients to transmit photographs and have questions answered about their recovery process through a smartphone application. TM has even been used to diagnose and treat venous thromboembolism (VTE) during spaceflight [11] . Nonetheless, data concerning TM for patients with vascular disease remain limited, and previous examples typically focus on individual disease processes rather than the full spectrum of vascular conditions. As a result, clinicians were left to devise their own processes as the COVID-19 outbreak expanded. Prior to the COVID-19 outbreak, TM in the Vanderbilt Heart and Vascular Institute (VHVI) at Vanderbilt University Medical Center (VUMC) was limited to anticoagulation management and remote device monitoring by the electrophysiology and HF services. On March 30, 2020, the Governor of Tennessee issued an executive "Safer at Home" order requiring all residents, with some exceptions, to remain in their homes as a way to reduce the impact of COVID-19 [12] . In anticipation of this order, VUMC rapidly authorized video TM and embedded it into our Epic-based electronic health record (EHR) (Epic Systems, Verona, WI). For providers, this was launched by clicking an icon next to each outpatient encounter, which then launched the Zoom video platform (Zoom Video Communications, San Jose, CA). Patients similarly launched Zoom from a HIPAA-compliant, web-based portal referred to as "My Health at Vanderbilt," which predated the pandemic and also houses information regarding appointments, laboratory data, and imaging results. Patients and providers were able to interact via Zoom on webcam-equipped computers, smartphone, and tablets. Backup imaging platforms to account for unforeseen technology issues included Apple Facetime, Facebook Messenger, Google Hangouts video, Whatsapp video chat, and Skype. In rare cases, either due to technology issues or unreliable internet access, these video encounters were converted to telephone encounters. Similar to an in-person encounter, a TM visit includes a full history of present illness as well as review of each patient's medical and surgical history, current medications, allergies, social history, family history, and review of systems. For the physical exam, patients obtained their own blood pressure if a sphygmomanometer was available. Our team instructed patients on measuring their own radial pulse, and patients were questioned regarding any irregularity of their pulse. If a scale was available, patients provided their weight and self-reported height. We asked patients to move their faces close to the camera to assess for craniofacial abnormalities, as in cases of possible connective tissue disorders, as well as scleral icterus or oropharyngeal abnormalities. A crude assessment for jugular venous distension was similarly performed by having patients move the camera to the neck area. We observed patients' chest wall expansion with breathing, and we asked them to palpate their abdomens for tenderness. Patients then flipped their phone screens or placed their camera on the floor to show their lower extremities. To determine if the lower extremities were swollen, we asked the patient to press their finger into the skin to assess for pitting edema. We were also able to assess for the presence of varicose, reticular, and spider veins, lymphedematous changes in the foot, ulcers, hair loss, and skin color changes. In many cases, patients sent additional photos via our EHR's secure messaging platform if better resolution was required or if skin changes fluctuated over time. After the physical examination, the provider would share their EHR computer screen with the patient to review laboratory testing and imaging. After a joint discussion of management recommendations, follow-up testing and appointments were arranged by clinical support staff. Because our vascular medicine practice routinely cares for patients in other states, licensing became a challenge. Initially, patients were required to cross the state line into Tennessee in order to complete TM visits. However, nearby states, including Kentucky, Alabama, and Mississippi, quickly authorized emergency temporary licensure, primarily for established patients. Notably, the licensure authorization often differed between physicians and advanced practice nurse practitioners, so our support staff worked to confirm both patient location and provider licensure status before each clinic session. The vascular medicine team at VUMC includes three vascular medicine attending physicians, one vascular medicine nurse practitioner, one nurse, and two medical assistants. During the COVID-19 pandemic, our roles shifted to collaboratively launch telemedicine. Prior to COVID-19 pandemic, the vascular medicine group would typically see up to 90 inpatient and outpatient visits each week. Once TM was activated, it became clear we needed a strategy to help patients receive care while minimizing exposure risk. As a team, we created a diagnosis-based triage protocol that was utilized by all providers for both outpatient (Figure 1) In recent years, policymakers have sought to reinvent American healthcare by replacing its fee-for-service foundations with a value-based care framework. Although TM is a logical component of such a framework, there remain significant burdens to providing video TM visits, particularly surrounding reimbursement. Due, in part, to a lack of other viable options during the COVID-19 pandemic, policymakers implemented a number of temporary actions that ultimately relaxed regulations for TM and encouraged home-and community-based management. The adoption of TM may be an unanticipated silver lining of COVID-19 for patients and providers alike. It has reduced travel time, fuel costs, and parking annoyance for patients and providers alike and can be easily adapted to provide visits outside of typical clinic hours. In many cases, TM allows for more patient-clinician interaction as a result of less time needed for rooming, documentation, and some components of the physical exam. Also, it allows providers to digitally share their computer screen and review laboratory findings and imaging. Moving forward, the future of TM remains unclear. Policymakers have not yet made long-term decisions regarding reimbursement and emergency licensure. Many technology platforms still do not provide adequate privacy for healthcare interactions. Also, there are issues surrounding patients' access to technology and reliable internet service, which may further healthcare disparities. Finally, we will not have data on the quality and efficacy of care provided by TM for many months. Nonetheless, we have learned valuable lessons from this rapid expansion of TM in our hospital. It is shortsighted to only view this expansion of TM as a solution to barriers caused by COVID-19. Disruptions in patients' ability to receive care routinely occur following tornadoes, floods, and other natural disasters, and Middle Tennessee has already experienced several such disruptions this year alone. We hope that our collective experience will inform our response to these and other challenges in the future. Examples Educational websites • Pre-operative information for patients to improve their preparedness for surgery • Post-operative programs to assist patients in their recovery process Telecoaching • Real-time individualized phone, video, or web-based text interactions with patients to identify symptoms in an accurate and timely manner and to effectively change their behavior with supportive guidance Telemonitoring • Inpatient or ambulatory tracking of patients through wireless measurement of vital parameters or activity or through electronic questionnaires regarding health. • Coaching, feedback, and or pharmacologic interventions might be provided based on these data Telerehabilitation WHO Director-General's opening remarks at the media briefing on COVID-19 -11 Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study An increased severity of peripheral arterial disease in the covid-19 era Moving Beyond the Walls of the Clinic: Opportunities and Challenges to the Future of Telehealth in Heart Failure IP223 Are Patients With Critical Limb Ischemia Ready for Telemedicine? Telemedicine in patients with peripheral arterial disease: is it worth the effort? Feasibility of an Image-Based Mobile Health Protocol for Postoperative Wound Monitoring Venous Thrombosis during Spaceflight State of Tennessee Executive Order by the Governor No